{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:34:07Z","timestamp":1792802047141,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T00:00:00Z","timestamp":1542412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13643-018-0874-7","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T00:10:42Z","timestamp":1542413442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-3084","authenticated-orcid":false,"given":"Witness","family":"Mapanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Girdler-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingairai A.","family":"Feresu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsungai","family":"Chipato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,17]]},"reference":[{"key":"874_CR1","unstructured":"World Health Organisation. Human papilloma virus (HPV). Available at \n                    http:\/\/www.who.int\/immunization\/topics\/hpv\/en\/\n                    \n                   Accessed 23 May 2018."},{"key":"874_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bpobgyn.2004.10.002","volume":"19","author":"ZM Chirenje","year":"2005","unstructured":"Chirenje ZM. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005;19:269\u201376.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"874_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jnci\/dji072","volume":"97","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Polesel J, Rickenbach M. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute. 2005;97(6):425\u201332.","journal-title":"Journal of the National Cancer Institute"},{"key":"874_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2407-6-135","volume":"6","author":"JR Moodley","year":"2006","unstructured":"Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L, et al. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer. 2006;6:135.","journal-title":"BMC Cancer"},{"issue":"2","key":"874_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N, Mustafa RA, Sch\u00fcnemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, et al. World Health Organization Guidelines for treatment of cervical intraepithelial. Neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 2016;132(2):252\u20138.","journal-title":"Int J Gynaecol Obstet"},{"key":"874_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2407-14-161","volume":"14","author":"C Sichanh","year":"2014","unstructured":"Sichanh C, Quet F, Chanthavilay P, Diendere J, Latthaphasavang V, Longuet C, et al. Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR. BMC Cancer. 2014;14:161.","journal-title":"BMC Cancer"},{"issue":"29","key":"874_CR7","first-page":"1","volume":"16","author":"S Finocchario-Kessler","year":"2016","unstructured":"Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016;16(29):1\u201325.","journal-title":"BMC Womens Health"},{"issue":"3","key":"874_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/0971-5851.92808","volume":"32","author":"GA Mishra","year":"2011","unstructured":"Mishra GA, Pimple SA, Shastri SS. An overview of prevention and early detection of cervical cancers. Indian J Med Paediatr Oncol. 2011;32(3):125\u201332.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"1","key":"874_CR9","first-page":"742","volume":"7","author":"MS Fallala","year":"2015","unstructured":"Fallala MS, Mash R. Cervical cancer screening: safety, acceptability and feasibility of a single-visit approach in Bulawayo, Zimbabwe. Afr J Prm Health Care Fam Med. 2015;7(1):742\u20139.","journal-title":"Afr J Prm Health Care Fam Med"},{"issue":"5","key":"874_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/jnu.12232","volume":"48","author":"DM McFarland","year":"2016","unstructured":"McFarland DM, Gueldner SM, Mogobe KD. Integrated review of barriers to cervical cancer screening in sub-Saharan Africa. J Nurs Scholarsh. 2016;48(5):490\u20138.","journal-title":"J Nurs Scholarsh"},{"issue":"2","key":"874_CR11","first-page":"127","volume":"79","author":"ZM Chirenje","year":"2001","unstructured":"Chirenje ZM, Rusakaniko S, Kirumbi L, Ngwalle EW, Makuta-Tlebere PP, Kaggwa S, Mpanju-Shumbusho W, Makoae L. Situation analysis for cervical cancer diagnosis and treatment in East, Central and Southern African countries. World Health Organisation. 2001;79(2):127\u201332.","journal-title":"World Health Organisation"},{"issue":"1","key":"874_CR12","doi-asserted-by":"publisher","first-page":"e12444","DOI":"10.1111\/ecc.12444","volume":"26","author":"J.N.W. Lim","year":"2016","unstructured":"Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in sub-Sahara Africa: a systematic review. Eur J Cancer Care (Engl). 2017;26(1). \n                    https:\/\/doi.org\/10.1111\/ecc.12444\n                    \n                   Epub 07 Feb 2016.","journal-title":"European Journal of Cancer Care"},{"key":"874_CR13","volume-title":"Implementation of HPV vaccination in South Africa","author":"Public Health Association of South Africa","year":"2015","unstructured":"Public Health Association of South Africa. Implementation of HPV vaccination in South Africa. 2015."},{"key":"874_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","volume":"21","author":"RG Ghebre","year":"2017","unstructured":"Ghebre RG, Grover S, Xu MJ, Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: past, present and future. Gynecologic Oncology Reports. 2017;21:101\u20138.","journal-title":"Gynecologic Oncology Reports"},{"issue":"1","key":"874_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1586\/14760584.2016.1110025","volume":"15","author":"EM Kojic","year":"2016","unstructured":"Kojic EM, Rana AI, Cu-Uvin S. Human papillomavirus vaccination in HIV-infected women: need for increased coverage. Expert review of vaccines. 2016;15(1):105\u201317. \n                    https:\/\/doi.org\/10.1586\/14760584.2016.1110025\n                    \n                  .","journal-title":"Expert review of vaccines"},{"issue":"1","key":"874_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13643-017-0484-9","volume":"6","author":"W Mapanga","year":"2017","unstructured":"Mapanga W, Elhakeem A, Feresu SA, Maseko F, Chipato T. Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol. Syst Rev. 2017;6(1):91 10.1186\/s13643-017-0484-9.","journal-title":"Syst Rev"},{"issue":"7","key":"874_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med. 2009;6(7):e1000097 \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1000097\n                    \n                  .","journal-title":"PLoS Med"},{"key":"874_CR18","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Quality Assessment Scale Available at \n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                   [Accessed 11 Oct 2016]."},{"key":"874_CR19","unstructured":"NIH Study Quality Assessment Tools. Available at \n                    https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools\n                    \n                   [Accessed 2 Oct 2018]."},{"issue":"4","key":"874_CR20","doi-asserted-by":"publisher","first-page":"e0118568","DOI":"10.1371\/journal.pone.0118568","volume":"10","author":"Megan J. Huchko","year":"2015","unstructured":"Huchko MJ, Sneden J, Zakaras JM, Smith-McCune K, Sawaya G, Maloba M, Bukusi E, et al. A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to visual inspection with Lugol\u2019s iodine for cervical cancer screening in HIV-infected women. Plos One. 2015. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0118568\n                    \n                  .","journal-title":"PLOS ONE"},{"issue":"16","key":"874_CR21","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1097\/QAD.0b013e32833e163e","volume":"24","author":"L Kuhn","year":"2010","unstructured":"Kuhn L, Wang C, Tsai WY, Wright TC, Denny L. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. AIDS. 2010;24(16):2553\u201361.","journal-title":"AIDS"},{"issue":"3","key":"874_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2471\/BLT.13.122051","volume":"92","author":"MJ Huchko","year":"2014","unstructured":"Huchko MJ, Sneden J, Leslie HH, Abdulrahim N, Maloba M, Bukusi E, et al. A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. Bull World Health Organ. 2014;92(3):195\u2013203.","journal-title":"Bull World Health Organ"},{"key":"874_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40661-017-0041-1","volume":"4","author":"D Obiri-Yeboah","year":"2017","unstructured":"Obiri-Yeboah D, Adu-Sarkodie Y, Djigma F, Akakpo K, Aniakwa-Bonsu E, Amoako-Sakyi D, et al. Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana. Gynecol Oncol Res Pract. 2017;4:5.","journal-title":"Gynecol Oncol Res Pract"},{"issue":"1","key":"874_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12905-017-0448-1","volume":"17","author":"D Obiri-Yeboah","year":"2017","unstructured":"Obiri-Yeboah D, Adu-Sarkodie Y, Djigma F, Hayfron-Benjamin A, Abdul L, Simpore J, et al. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women. BMC Womens Health. 2017;17(1):86.","journal-title":"BMC Womens Health"},{"issue":"3","key":"874_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/LGT.0000000000000090","volume":"19","author":"P Bansil","year":"2015","unstructured":"Bansil P, Lim J, Byamugisha J, Kumakech E, Nakisige C, Jeronimo JA. Performance of cervical cancer screening techniques in HIV-infected women in Uganda. J Low Genit Tract Dis. 2015;19(3):215\u20139.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"874_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ygyno.2017.11.002","volume":"148","author":"P Cholli","year":"2018","unstructured":"Cholli P, Bradford L, Manga S, Nulah K, Kiyang E, Manjuh F, et al. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: findings of initial screening and one-year follow-up. Gynecol Oncol. 2018;148(1):118\u201325.","journal-title":"Gynecol Oncol"},{"issue":"18","key":"874_CR27","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1097\/01.aids.0000432472.92120.1b","volume":"27","author":"MH Chung","year":"2013","unstructured":"Chung MH, McKenzie K, De Vuyst H, et al. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy. AIDS. 2013;27(18):2909\u201319.","journal-title":"AIDS"},{"issue":"4","key":"874_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ijc.28712","volume":"135","author":"MA Dartell","year":"2014","unstructured":"Dartell MA, Rasch V, Ifner T, et al. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women. Int J Cancer. 2014;135(4):896\u2013904.","journal-title":"Int J Cancer"},{"issue":"1","key":"874_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144905","volume":"11","author":"C Firnhaber","year":"2016","unstructured":"Firnhaber C, Goeieman B, Faesen M, Levin S, Williams S, Rameotshela S, et al. Prospective one year follow up of HIV infected women screened for cervical cancer using visual inspection with acetic acid, cytology and human papillomavirus testing in Johannesburg South Africa. PLoS One. 2016;11(1):e0144905.","journal-title":"PLoS One"},{"issue":"4","key":"874_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/QAD.0b013e32835b1041","volume":"27","author":"S Joshi","year":"2013","unstructured":"Joshi S, Sankaranarayanan R, Muwonge R, Kulkarni V, Somanathan T, Divate U. Screening of cervical neoplasia in HIV-infected women in India. AIDS. 2013;27(4):607\u201315.","journal-title":"AIDS"},{"issue":"5","key":"874_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/1545109710390216","volume":"10","author":"K Lim","year":"2011","unstructured":"Lim K, Davidson A, Harwell J, Thay S, Boardman LA, Feller E, et al. Comparing visual inspection with acetic acid to cytology in detection of precancerous lesions of the cervix in HIV-infected Cambodian women. J Int Assoc Physicians AIDS Care (Chic). 2011;10(5):283\u20136.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"issue":"2","key":"874_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/LGT.0b013e3182320f0c","volume":"16","author":"H Mabeya","year":"2012","unstructured":"Mabeya H, Khozaim K, Liu T, et al. Comparison of conventional cervical cytology versus visual inspection with acetic acid (VIA) among HIV-infected women in western Kenya. J Low Gen Tract Dis. 2012;16(2):92\u20137.","journal-title":"J Low Gen Tract Dis"},{"issue":"1","key":"874_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4102\/ajlm.v5i1.278","volume":"5","author":"P Michelow","year":"2016","unstructured":"Michelow P, Sherrin A, Rossouw L, Mohaleamolla S, Evans D, Swarts A, et al. Performance of the Cellslide((R)) automated liquid-based cytology system amongst HIV-positive women. Afr J Lab Med. 2016;5(1):278.","journal-title":"Afr J Lab Med"},{"issue":"1","key":"874_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ijc.25971","volume":"130","author":"VV Sahasrabuddhe","year":"2012","unstructured":"Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, et al. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Int J Cancer. 2012;130(1):234\u201340.","journal-title":"Int J Cancer"},{"issue":"6","key":"874_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/01443610802259977","volume":"28","author":"L Akinwuntwan","year":"2008","unstructured":"Akinwuntwan L, Adesina OA, Okolo CA, et al. Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women. J Obstet and Gynaecol. 2008;28(6):638\u201341.","journal-title":"J Obstet and Gynaecol"},{"issue":"4","key":"874_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/bjc.2016.207","volume":"115","author":"M Segondy","year":"2016","unstructured":"Segondy M, Kelly H, Djima F, et al. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study. Br J Cancer. 2016;115(4):425\u201330.","journal-title":"Br J Cancer"},{"issue":"2","key":"874_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/QAI.0000000000000270","volume":"67","author":"AC Bateman","year":"2014","unstructured":"Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, et al. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2014;67(2):212\u20135. \n                    https:\/\/doi.org\/10.1097\/QAI.0000000000000270\n                    \n                  .","journal-title":"J Acquir Immune Defic Syndr"},{"key":"874_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-4755-7-4","volume":"7","author":"T Mutyaba","year":"2010","unstructured":"Mutyaba T, Mirembe F, Sandin S, Weiderpass E. Evaluation of \u2018see-see and treat\u2019 strategy and role of HIV on cervical cancer prevention in Uganda. Reprod Health. 2010;7:4.","journal-title":"Reprod Health"},{"issue":"2","key":"874_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/QAI.0000000000000428","volume":"68","author":"J Ngou","year":"2015","unstructured":"Ngou J, Gilham C, Omar T, Goumbri-Lompo O, Doutre S, Michelow P, et al. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women. J Acquir Immune Defic Syndr. 2015;68(2):162\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"874_CR40","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1128\/JCM.02144-13","volume":"51","author":"J Ngou","year":"2013","unstructured":"Ngou J, Magooa MP, Gilham C, Djigma F, Didelot MN, Kelly H, et al. Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human papillomavirus DNA in cervical samples from HIV-1-infected African women. J Clin Microbiol. 2013;51(12):4240\u20132.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"874_CR41","doi-asserted-by":"publisher","first-page":"e53494","DOI":"10.1371\/journal.pone.0053494","volume":"8","author":"C Firnhaber","year":"2013","unstructured":"Firnhaber C, Mayisela N, Mao L, et al. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One. 2013;8(1):e53494.","journal-title":"PLoS One"},{"issue":"9","key":"874_CR42","doi-asserted-by":"publisher","first-page":"e012547","DOI":"10.1136\/bmjopen-2016-012547","volume":"6","author":"TJ Wu","year":"2016","unstructured":"Wu TJ, Smith-McCune K, Reuschenbach M, von Knebel DM, Maloba M, Huchko MJ. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. BMJ Open. 2016;6(9):e012547.","journal-title":"BMJ Open"},{"issue":"3","key":"874_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/LGT.0000000000000206","volume":"20","author":"CJ Chibwesha","year":"2016","unstructured":"Chibwesha CJ, Frett B, Katundu K, et al. Clinical performance validation of 4 point-of-care cervical cancer screening tests in HIV-infected women in Zambia. J Low Gen Tract Dis. 2016;20(3):218\u201323.","journal-title":"J Low Gen Tract Dis"},{"issue":"9","key":"874_CR44","doi-asserted-by":"publisher","first-page":"e0137299","DOI":"10.1371\/journal.pone.0137299","volume":"10","author":"PC Adamson","year":"2015","unstructured":"Adamson PC, Huchko MJ, Moss AM, Kinkel HF, Medina-Marino A. Acceptability and accuracy of cervical cancer screening using a self-collected tampon for HPV messenger-RNA testing among HIV-infected women in South Africa. PLoS One. 2015;10(9):e0137299.","journal-title":"PLoS One"},{"key":"874_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/IJWH.S103868","volume":"9","author":"M Viviano","year":"2017","unstructured":"Viviano M, DeBeaudrap P, Tebeu PM, Fouogue JT, Vassilakos P, Petignat P. A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa. Int J Women\u2019s Health. 2017;9:69\u201379.","journal-title":"Int J Women\u2019s Health"},{"issue":"1","key":"874_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.9745\/GHSP-D-15-00325","volume":"4","author":"N Shiferaw","year":"2016","unstructured":"Shiferaw N, Salvador-Davila G, Kassahun K, et al. The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia. Successes and lessons learned. Glob Health Sci Pract. 2016;4(1):87\u201398.","journal-title":"Glob Health Sci Pract"},{"issue":"9895","key":"874_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u201399.","journal-title":"Lancet"},{"key":"874_CR48","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMcp1210379","volume":"369","author":"M Schiffman","year":"2013","unstructured":"Schiffman M, Solomon D. Cervical-cancer screening with human papillomavirus and cytologic cotesting. N Engl J Med. 2013;369:2324\u201331.","journal-title":"N Engl J Med"},{"issue":"10","key":"874_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/v9100293","volume":"9","author":"Samuel Alizon","year":"2017","unstructured":"Alizon S, Murall CL, Bravo IG. Why human papillomavirus acute infections matter. Viruses. 2017;9(293). \n                    https:\/\/doi.org\/10.3390\/v9100293\n                    \n                  .","journal-title":"Viruses"},{"issue":"6","key":"874_CR50","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/infdis\/jiq116","volume":"203","author":"PE Castle","year":"2011","unstructured":"Castle PE, Rodriguez AC, Burk RD, Herrero R, Wacholder S, Hildesheim A, et al. Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer. J Infect Dis. 2011;203(6):814\u201322.","journal-title":"J Infect Dis"},{"issue":"2","key":"874_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1470-2045(13)70605-3","volume":"15","author":"PE Gravitt","year":"2014","unstructured":"Gravitt PE, Rositch AF. HPV self-testing and cervical cancer screening coverage. Lancet Oncol. 2014;15(2):128\u20139.","journal-title":"Lancet Oncol"},{"key":"874_CR52","first-page":"2014","volume-title":"AMC 054: safety and immunogenicity of the quadrivalent HPV vaccine in Indian HIV-infected women","author":"J Palefsky","year":"2014","unstructured":"Palefsky J, Poongulali S, Lensing SY, Lee JY, Da Costa M, Jeeva A, Iqbal S, Kumarsami N. AMC 054: safety and immunogenicity of the quadrivalent HPV vaccine in Indian HIV-infected women. Boston: Conference on Retroviruses and Opportunistic Infections; 2014. p. 2014."},{"issue":"1","key":"874_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/cid\/ciu238","volume":"59","author":"EM Kojic","year":"2014","unstructured":"Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, et al. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clin Infect Dis. 2014;59(1):127\u201335.","journal-title":"Clin Infect Dis"},{"issue":"48","key":"874_CR54","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1016\/j.vaccine.2013.09.032","volume":"31","author":"L Denny","year":"2013","unstructured":"Denny L, Hendricks B, Gordon C, Thomas F, Hezareh M, Dobbelaere K, Durand C, Herve C, Descamps D. Safety and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study. Vaccine. 2013;31(48):5745\u201353.","journal-title":"Vaccine"},{"issue":"5","key":"874_CR55","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/cid\/cit319","volume":"57","author":"JA Kahn","year":"2013","unstructured":"Kahn JA, Xu J, Kapogiannis BG, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires KE. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis. 2013;57(5):735\u201344.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"874_CR56","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.4161\/hv.27925","volume":"10","author":"L Toft","year":"2014","unstructured":"Toft L, Tolstrup M, Muller M, Sehr P, Bonde J, Storgaard M, Ostergaard L, Sogaard OS. Comparison of the immunogenicity of Cervarix(R) and Gardasil(R) human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults. Hum Vaccin Immunother. 2014;10(5):1147\u201354.","journal-title":"Hum Vaccin Immunother"},{"issue":"43","key":"874_CR57","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1016\/j.vaccine.2014.08.011","volume":"32","author":"V Giacomet","year":"2014","unstructured":"Giacomet V, Penagini F, Trabattoni D, Vigano A, Rainone V, Bernazzani G, Bonardi CM, Clerici M, Bedogni G, Zuccotti GV. Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults. Vaccine. 2014;32(43):5657\u201361.","journal-title":"Vaccine"},{"issue":"1","key":"874_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1586\/14760584.2016.1110025","volume":"15","author":"EM Kojic","year":"2016","unstructured":"Kojic EM, Rana AI, Cu-Uvin S. Human papillomavirus in HIV-infected women: need for increased coverage. Expert Rev Vaccines. 2016;15(1):105\u201317.","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"874_CR59","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/cid\/ciu094","volume":"58","author":"H Masur","year":"2014","unstructured":"Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(9):1308\u201311.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"874_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.amepre.2003.09.012","volume":"26","author":"P Briss","year":"2004","unstructured":"Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26(1):67\u201380.","journal-title":"Am J Prev Med"},{"key":"874_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1478-7547-10-2","volume":"10","author":"J Miot","year":"2012","unstructured":"Miot J, Wagner M, Khoury H, Rindress D, Goetghebeur M. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa. Cost Effectiveness and Resource Allocation. 2012;10:2.","journal-title":"Cost Effectiveness and Resource Allocation"},{"key":"874_CR62","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.jval.2015.08.003","volume":"18","author":"K Pedersen","year":"2015","unstructured":"Pedersen K, Sorbye SW, Burger EA, Lonnberg S, Kristiansen IS. Using decision-analytic modeling to isolate interventions that are feasible, efficient and optimal: an application from the Norwegian cervical cancer-screening program. Value Health. 2015;18:1088\u201397.","journal-title":"Value Health"},{"key":"874_CR63","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0140-6736(02)09832-X","volume":"360","author":"K Claxton","year":"2002","unstructured":"Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet. 2002;360:711\u20135.","journal-title":"Lancet"},{"key":"874_CR64","first-page":"S3\/155","volume":"24S3","author":"SJ Goldie","year":"2006","unstructured":"Goldie SJ, Goldhaber-Fiebert JD, Garnett GP. Chapter 18: public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modelling. Vaccine. 2006;24S3:S3\/155\u201363.","journal-title":"Vaccine"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0874-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-018-0874-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0874-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T19:03:06Z","timestamp":1573930986000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-018-0874-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,17]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1186\/s13643-018-0874-7","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,17]]},"assertion":[{"value":"4 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"WM is studying towards a PhD Epidemiology Degree at the School of Health Systems and Public Health, University of Pretoria, and is investigating on cervical cancer in low-income countries. BGB is a professor of Biostatistics at the Department of Epidemiology and Biostatistics at the University of Pretoria. ES is the Director of the South African National Cancer Registry. TC is a professor of Obstetrics and Gynaecology at the College of Health Sciences, University of Zimbabwe. SF is a professor of Biostatistics and Epidemiology at the Faculty of Health Sciences, University of Fort Hare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The Research Ethics Committee, Faculty of Health Science, University of Pretoria, reviewed the study (Ethics Reference Number: 146\/2016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"198"}}